止血藥的臨床應用分析
發(fā)布時間:2018-05-15 22:20
本文選題:止血藥 + 藥物利用; 參考:《中國藥物評價》2016年04期
【摘要】:目的:了解止血藥的應用特點與趨勢。方法:對我院2015年住院患者應用止血藥的銷售金額、用藥頻度(DDDs)、日均費用(DDC)及金額排序/DDDs排序(A/B)值等進行回顧性分析。結果:我院蛇毒血凝酶銷售金額位居首位;DDDs排序列前3位的是酚磺乙胺、蛇毒血凝酶、維生素K1,抗纖溶藥中氨甲環(huán)酸DDDs位居首位,酚磺乙胺A/B值高而DDC值低。結論:我院住院患者應用止血藥以促凝血功能藥為主,尤其是血凝酶類藥物。醫(yī)院應加強外科圍手術期止血藥臨床合理使用。
[Abstract]:Objective: to understand the application characteristics and trend of hemostatic drugs. Methods: the sales amount of hemostatic drugs, the frequency of drug use, the daily average cost (DDCs) and the value of A / B ratio of sum of money / DDDs were analyzed retrospectively. Results: the number of venom hemagglutinase in our hospital ranked first in the order of DDDs: phenolsulfonethylamine, snake venom hemagglutinase, vitamin K1, and DDDs, the value of phenolsulfonethylamine A / B was high and the DDC value was low. Conclusion: hemostatic drugs are mainly used in our hospital, especially hemagglutinin. Hospital should strengthen the rational use of surgical hemostatic drugs in perioperative period.
【作者單位】: 安徽省蚌埠市第三人民醫(yī)院藥學部;
【分類號】:R973.1
【相似文獻】
相關期刊論文 前10條
1 陳明;蛇毒血凝酶治療肺結核大咯血臨床觀察[J];臨床肺科雜志;2005年03期
2 易濤平;邱祖龍;;蛇毒血凝酶治療肺結核大咯血臨床觀察[J];中國社區(qū)醫(yī)師(醫(yī)學專業(yè));2012年04期
3 潘夢W,
本文編號:1894196
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/1894196.html
最近更新
教材專著